Clinical Trial Update: Safety and Efficacy of Folfox4 + Weekly Cetuximab vs Folfox 4+Biweekly Cetuximab by Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing Folfox4 plus weekly cetuximab versus Folfox4 plus biweekly cetuximab in metastatic colorectal cancer to assess safety and efficacy. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• ERBITUX (cetuximab)
• Eloxatin (oxaliplatin)
• Leucovorin (folinic acid)

Snippet

Sponsor: Central European Cooperative Oncology Group | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED